International society of oncology pharmacy practitioners (ISOPP) position statement: The role of oncology pharmacy practitioners in immunotherapy treatment with immune checkpoint inhibitors for malignant conditions-Reference-Cited by-同舟云学术

International society of oncology pharmacy practitioners (ISOPP) position statement: The role of oncology pharmacy practitioners in immunotherapy treatment with immune checkpoint inhibitors for malignant conditions

Published:2022-04-05 Issue: Volume: Page:107815522210901
ISSN:1078-1552
Container-title:Journal of Oncology Pharmacy Practice
language:en
Short-container-title:J Oncol Pharm Pract

Author:

Walker Andrew¹^ORCID,Chan Alexandre²,Labra Constanza Cortés³,de Lemos Mario L.⁴^ORCID,Geirnaert Marc⁵^ORCID,Albert-Marí María Asunción⁶,Atik Elif Aras⁷^ORCID,Borlagdan Jared⁸^ORCID,Crespo Andrea⁹,Danilak Melanie¹⁰,Kandemir Esin Aysel¹¹^ORCID,Lim CheaXin¹²,Alabelewe Ramatu Mas’ud¹³,Mutiara Rina¹⁴,Tewthanom Karunrat¹⁵^ORCID,Yim Barbara¹⁶,Nakashima Lynne⁴^ORCID

Affiliation:

1. The Calderdale And Huddersfield NHS Foundation Trust, Huddersfield, UK

2. School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, California, USA

3. Bradford Hill Oncology Research Center, Santiago, Chile

4. BC Cancer, Vancouver, British Columbia, Canada

5. Cancer Care Manitoba, Winnipeg, Manitoba, Canada

6. Hospital Universitario y Politecnico La Fe, Spain

7. Hacettepe University Faculty of Pharmacy, Turkey

8. Oregon Health & Science University, Portland, Oregon, USA

9. Cancer Care Ontario (Ontario Health), Toronto, Ontario, Canada

10. Alberta Health Services, Edmonton, Alberta, Canada

11. Turkish Medicines and Medical Devices Agency, Ankara, Turkey

12. The Brunei Cancer Centre, Bandar Seri Begawan, Brunei Darussalam

13. Ahmadu Bello University Teaching Hospital Zaria, Kaduna, Nigeria

14. Drcipto Mangunkusumo Hospital, Dki Jakarta, Indonesia

15. Faculty of Pharmacy, Silpakorn University, Meaung, NakhonPathom, Thailand

16. JHS Hospital of Cook County, Chicago, Illinois, USA

Abstract

Oncology pharmacists, pharmacy technicians and assistants are key members of the multidisciplinary health care team (MHT) caring for patients receiving immunotherapy with immune checkpoint inhibitors. The International Society of Oncology Pharmacy Practitioners (ISOPP) developed this position statement to provide guidance on the role of oncology pharmacy practitioners in caring for patients receiving immune checkpoint inhibitors. Four key recommendations were identified: 1) participation as an integrated, collaborative member of the MHT; 2) provision of education and training for patients, students, residents, fellows and other members of the MHT; 3) involvement in clinical governance to optimise the use of immune checkpoint inhibitors and 4) involvement in research and development in the field of immunotherapy. In summary, oncology pharmacy practitioners play essential roles within the MHT in caring for patients receiving immune checkpoint inhibitors.

Publisher

SAGE Publications

Subject

Pharmacology (medical),Oncology

Link

http://journals.sagepub.com/doi/pdf/10.1177/10781552221090199

Reference60 articles.

1. The ever‐increasing importance of cancer as a leading cause of premature death worldwide

2. Adverse event profile for immunotherapy agents compared with chemotherapy in solid organ tumors: a systematic review and meta-analysis of randomized clinical trials

3. Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma

4. CTLA-4 and PD-1 Pathways